Literature DB >> 7273467

Sjögren-Larsson syndrome in Sweden. A clinical, genetic and epidemiological study.

S Jagell, K H Gustavson, G Holmgren.   

Abstract

Sjögren-Larsson syndrome (SLS), originally described in Sweden, has been studied in a countrywide survey. A total of 58 SLS patients in 41 families were traced, 35 of them still alive. Thirty patients, 23 alive and seven deceased, have not been reported earlier. The mean incidences per 100,000 in the years 1901-1977 were 0.6 in the whole of Sweden, 10.2 in the county of Västerbotten and 2.7 per 100,000 in the county of Norrbotten. In the above-mentioned areas, the prevalence figures of SLS on 31st December 1978 were estimated to be 0.4, 8.3 and 2.6 per 100,000 persons, the frequencies of SLS gene carriers 0.5, 2.0 and 1.0%, and the gene frequencies 0.002, 0.010 and 0.005, respectively. Of the 58 identified Swedish SLS patients, 45 were born in a restricted area in the northeast of Sweden.

Entities:  

Mesh:

Year:  1981        PMID: 7273467     DOI: 10.1111/j.1399-0004.1981.tb00704.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  17 in total

1.  Confirmation of linkage of Sjögren-Larsson syndrome to chromosome 17 in families of different ethnic origins.

Authors:  M Lacour; H R Middleton-Price; J I Harper
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

2.  Carrier detection for Sjögren-Larsson syndrome.

Authors:  T L Kelson; D A Craft; W B Rizzo
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Sjogren - Larsson Syndrome.

Authors:  A K Dubey; R K Gupta; Arvind Gupta
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Computed tomography in Sjögren-Larsson syndrome.

Authors:  J M Gomori; V Leibovici; A Zlotogorski; I Wirguin; S Haham-Zadeh
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

5.  Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.

Authors:  W B Rizzo; A L Dammann; D A Craft
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

Review 6.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

7.  Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.

Authors:  W B Rizzo; D A Craft
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Sjögren-Larsson syndrome: a rare disease of the skin and central nervous system.

Authors:  Ujjawal Roy; Urmila Das; Alak Pandit; Anjan Debnath
Journal:  BMJ Case Rep       Date:  2016-04-19

9.  MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy.

Authors:  Michèl A A P Willemsen; Marinette Van Der Graaf; Marjo S Van Der Knaap; Arend Heerschap; Peter H M F Van Domburg; Fons J M Gabreëls; Jan J Rotteveel
Journal:  AJNR Am J Neuroradiol       Date:  2004-04       Impact factor: 3.825

10.  Sjögren-Larsson syndrome in two brothers: a case report.

Authors:  Farid Rezaei Moghaddam; Farid Safar; Mahsa Asheghan; Zahra Reza Soltani; Fatemeh Dehghani Zade
Journal:  Cases J       Date:  2009-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.